HomeAI · summaries
Storia in 7 fonti
AI-designed drug appears to turn back the body's biological clock in early trial
A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cryptobriefing.com
Insilico Medicine's rentosertib shows potential to slow aging in landmark Phase III trial
Insilico Medicine's AI-discovered drug rentosertib enters Phase III trials for lung fibrosis, targeting cellular senescence with implications for
- ·
thenextweb.com
Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
Six proteomic ageing clocks agreed patients on Insilico’s AI-designed lung drug looked younger. The authors cannot yet rule out the treated lung.
